Page 77 - IJB-6-3

Elemoso, et al.
BlueNalu, which employs several former science and the opportunities for commercialization
members of Organovo, plans to print thin slices forward. Once the limiting factors such as the
of layered fish tissues that consist of muscle cells, lack of adequate cell material are successfully
connective tissue, and fat cells, and combine it with addressed, we shall no doubt see more commercial
industrial-scale bioreactor system . Meatech products and services in regenerative medicine,
[87]
and Future Meat Technologies, two startups from space science, drug discovery, food industry, and
Israel, also plan to use bioprinting as a method perhaps even beyond that.
to combine multiple tissue types to create a final
product which would resemble natural meat cut Conflict of interest
texture. However, beyond bioprinting, they use The authors declare no conflict of interest.
different technologies; Meatech plans to use
umbilical cord samples as the prime source of References
cells, while future meat technologies, according to
their patents, plans to focus on bioreactor system 1. O’Brien CM, Holmes B, Faucett S, et al., 2015, Three-
development . Fork and Goode, an American Dimensional Printing of Nanomaterial Scaffolds for Complex
[88]
company led by Gabor Forgacs which is one of the Tissue Regeneration. Tissue Eng, 21:103–14. DOI: 10.1089/
bioprinting pioneers, has not unveiled any product ten.teb.2014.0168.
plans, but they have multiple patents relevant to 2. Wilson WC, Boland T, 2003, Cell and Organ Printing 1:
the printing of food products which were filed by Protein and Cell Printers. Anat Rec, 272a:491–6. DOI:
Organovo several years ago . 10.1002/ar.a.10057.
[89]
However, the application of bioprinting in 3. Mironov V, Boland T, Trusk T, 2003, Organ Printing: Computer-
consumer goods is not limited to the food industry aided Jet-based 3D Tissue Engineering. Trends Biotechnol,
only. Cellular agriculture in textile production also 21:157–61. DOI: 10.1016/s0167-7799(03)00033-7.
uses its techniques. BioLogic, based in MIT, uses 4. Dababneh AB, Ozbolat IT, 2014, Bioprinting Technology: A
bioprinting to create responsive biomaterial for Current State-of-the-Art Review. J Manuf Sci Eng, 136:61.
sportswear [90,91] , while Modern Meadows employs 5. Duan B, Hockaday LA, Kang KH, Butcher JT, 2013,
bioprinting to create artificial leather textiles. This Bioprinting of Heterogeneous Aortic Valve Conduits
novel approach has the potential to solve the issue with Alginate/Gelatin Hydrogels. J Biomed Mater Res,
of animal abuse in fashion industry, but there is 101A:1255–64. DOI: 10.1002/jbm.a.34420.
more – technologies used by this two companies, 6. Wang S, Lee JM, Yeong WY, 2007, Smart Hydrogels for
BioLogic’s approach in particular, allow us to create 3D Bioprinting. J Bioprinting, 1:3–14. DOI: 10.18063/
smart fabrics that could potentially revolutionize a ijb.2015.01.005.
wide range of industries. Sensors and actuators on 7. Campbell PG, Weiss LE, 2007, Tissue Engineering with the
nanoscale will transform everything, from fashion Aid of Inkjet Printers. Expert Opin Biol Ther, 7:1123–7.
to military applications, since they can adjust the 8. Skardal A, Mack D, Kapetanovic E, 2012, Bioprinted
properties of a wide range of materials in real time . Amniotic Fluid-Derived Stem Cells Accelerate Healing of
[92]
Large Skin Wounds. Stem Cells Transl Med, 1:792–802.
7 Conclusion DOI: 10.5966/sctm.2012-0088.
9. Keriquel V, Guillemot F, Arnault I, 2010, In Vivo Bioprinting
The practical applications described in this article for Computer and Robotic-assisted Medical Intervention:
demonstrate the evident potential of 3D bioprinting Preliminary Study in Mice. Biofabrication, 2:14. DOI:
for a number of industries. There is undoubtedly 10.1088/1758-5082/2/1/014101.
increasing interest from both private investors 10. Poietis Signs a Clinical Research Collaboration Contract
and governments as bioprinting can be applied to with the Assistance Publique Hôpitaux de Marseille (AP-
solving crucial and fundamental problems such HM) to Prepare the First Clinical Trial of a Bioprinted Skin.
as the lack of donor organs or the environmental Available from: https://www.poietis.com/poietis-signs-a-
impact of meat industry. This should propel both the clinical-research-collaboration-contract-with-the-assistance-

International Journal of Bioprinting (2020)–Volume 6, Issue 3 73